Sharon Larkin
Direktor/Vorstandsmitglied bei SENSEONICS HOLDINGS, INC.
Vermögen: 227 393 $ am 31.05.2024
Aktive Positionen von Sharon Larkin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SENSEONICS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 08.12.2021 | - |
Independent Dir/Board Member | 08.12.2021 | - | |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Direktor/Vorstandsmitglied | 01.12.2021 | - |
Karriereverlauf von Sharon Larkin
Ehemalige bekannte Positionen von Sharon Larkin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Verwaltungsdirektor | 25.04.2017 | 01.01.2020 |
Personalreferent | 25.04.2017 | 01.01.2020 | |
ABBOTT LABORATORIES | Personalreferent | 01.09.2011 | 01.09.2015 |
Ausbildung von Sharon Larkin
Georgia Institute of Technology | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Director/Board Member | 2 |
Human Resources Officer | 2 |
Chief Administrative Officer | 1 |
Sektoral
Health Technology | 3 |
Electronic Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ABBOTT LABORATORIES | Health Technology |
SENSEONICS HOLDINGS, INC. | Electronic Technology |
Private Unternehmen | 2 |
---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Technology |
- Börse
- Insiders
- Sharon Larkin
- Erfahrung